Today, the Â鶹ӳ» Overdose Data to Action (OD2A) program, which oversees the surveillance of opioid overdose in the state, announced that accidental drug overdose deaths among Â鶹ӳ»ns increased by 55% from 2019 to 2020.
Information from the Â鶹ӳ» State Unintentional Drug Overdose Reporting System (SUDORS) show deaths increased from 510 in 2019 to 788 in 2020. Overdoses among those under 25 years old have increased by nearly 3 times from 38 in 2019 to 106 in 2020. In Â鶹ӳ», communities of color continue to be disproportionally impacted. Overdoses among the Hispanic community have more than tripled from 2019 to 2020.
In 2020, among overdose decedents in Â鶹ӳ»:
- 1 in 2 had a mental health problem
- 3 in 4 had an identified non-alcohol related substance misuse problem
- 1 in 9 had ever received substance misuse treatment
- 1 in 9 had a history of previous overdose
- 1 in 11 had been recently released from a hospital prior to overdose
- 1 in 14 had a relapse (began opioid use after a period of quitting)
The opioid overdose antidote, Naloxone, is available free in communities statewide and the OD2A program encourages Â鶹ӳ»ns to learn about this life-saving resource. Fatal overdose is avoidable and in Â鶹ӳ» Naloxone can be obtained without a prescription. Over half of overdoses occur with a bystander present.
If an overdose occurs call 9-1-1 immediately. In 2015, Â鶹ӳ» adopted the Good Samaritan Overdose law. This law protects an individual from prosecution for many narcotic-related offenses when seeking medical assistance for another person for a drug-related emergency.
The Â鶹ӳ» State Opioid Response grant supports statewide Naloxone distribution. Information about Naloxone and trainings to use the opioid-antagonist can be found through NVopioidresponse.org
Â鶹ӳ»ns are encouraged to reach out to the following resources if they are looking for Naloxone or treatment resources:
Call: 1-800-273-8255 (Suicide Hotline)
Call: 1-775-784-8090 (Crisis Support)
Text: CARE to 839863
775-241-4212
1-844-289-0879
The full report is available at .
